Trends in the Notification Rates and Treatment Outcome of Tuberculosis in Shandong Province, China, 2005–2021
Qilin Han,Yifan Li,Yao Liu,Xuehan Zhu,Qiqi An,Yameng Li,Tingting Wang,Yuzhen Zhang,Yingying Li,Weiwei Fang,Ningning Tao,Huaichen Li
DOI: https://doi.org/10.2147/idr.s454076
2024-04-12
Infection and Drug Resistance
Abstract:Qilin Han, 1, 2 Yifan Li, 3 Yao Liu, 1 Xuehan Zhu, 1 Qiqi An, 4 Yameng Li, 5 Tingting Wang, 5 Yuzhen Zhang, 1, 2 Yingying Li, 5 Weiwei Fang, 1, 2 Ningning Tao, 1, &ast Huaichen Li 1, 2, &ast 1 Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People's Republic of China; 2 Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, People's Republic of China; 3 Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Shandong First Medical University (Affiliated Hospital of Shandong Academy of Medical Sciences), Jinan, Shandong, 250031, People's Republic of China; 4 Department of Pulmonary and Critical Care Medicine, Xingyi People's Hospital, Qianxinan, Guizhou, 561499, People's Republic of China; 5 Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ningning Tao, Department of Pulmonary and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People's Republic of China, Email Huaichen Li, Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Huaiyin District, Jinan, Shandong, 250021, People's Republic of China, Email Purpose: To analyze the time trends in the notification rates of registered tuberculosis (TB) and bacteriologically confirmed TB in Shandong Province. And analyze the changes in TB treatment outcomes during 2005– 2021. Patients and Methods: The information of TB patients registered in the Shandong Information Center for Disease Control and Prevention (CDC) was collected during 2005– 2021. We calculated the notification rates of registered TB and bacteriologically confirmed TB. Moreover, we calculated the year-to-year change rate of TB in treatment outcomes before and after COVID-19. The time trends were analyzed using the joinpoint regression method and illustrated as the annual percentage change (APC) of notification rates. Results: A total of 236,898 cases of TB were diagnosed during 2005– 2021, of which 51.11% were bacteriologically confirmed cases. Since 2008, the notification rates of registered TB have declined. The notification rates of bacteriologically confirmed TB had been declining during 2005– 2016, then remained stable after 2016. In subgroup, the notification rates of both registered TB and bacteriologically confirmed TB were higher among men, rural residents, and people aged ≥ 60 years. Compared with clinically confirmed TB, bacteriologically confirmed TB has shown higher rates of poor outcomes since 2008 and higher case fatality rate since 2005. The rate of poor outcomes remained stable during 2008– 2019. However, after the COVID-19 outbreak, the rate of poor outcomes and case fatality rate of TB has risen significantly. Conclusion: After unremitting efforts to fight against TB, the notification rates of registered TB and bacteriologically confirmed TB declined in Shandong Province. The rate of poor outcomes remained stable during 2008– 2019, then rise significantly after the COVID-19 outbreak. In the context of the long-term existence of COVID-19, further efforts should be made in TB diagnosis and treatment among high-risk population, especially with regard to males, rural residents and older adults. Keywords: tuberculosis, joinpoint regression, time trends, COVID-19 Tuberculosis (TB) is caused by the bacteria Mycobacterium tuberculosis (M. tb), which can be spread by respiratory droplets or aerosols, and infect its only host human beings. Bacteriologically confirmed TB including sputum smear positive, culture-positive and molecular test positive are more likely to spread M. tb and undergo TB-associated death. 1–3 The identification and management of bacteriologically confirmed TB cases are vital for TB control. Before the COVID-19 pandemic, TB not only ranked among the top ten causes of mortality worldwide but also stood as the most perilous infectious disease, surpassing human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS). 4 About 10.6 million new cases of active TB were reported by World Health Organization (WHO) in 2022. Ranking third after India and Indonesia, China accounts for 7.1% of TB cases. In 2022, TB infection led to 1.3 million -Abstract Truncated-
pharmacology & pharmacy,infectious diseases